Huzhou Wanbangde Investment's buyout of Dongliang Aluminium published by China's SAMR for simple case review
MLex Summary: Huzhou Wanbangde Investment’s buyout of Dongliang Aluminium from Wanbangde Pharmaceutical Holding has been published for a simple case review by the Antimonopoly Bureau of China’s State Administration for Market...To view the full article, register now.
Already a subscriber? Click here to view full article